Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ABLUMINUS Below the Knee (BTK) Drug Eluting Stent (DES) Registry (ABLUMINUS BTK) - First in Men

NCT04562740 is registered in ClinicalTrials.gov with Concept Medical Inc. as lead sponsor.

NCT NCT04562740
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04562740 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ABLUMINUS Below the Knee (BTK) Drug Eluting Stent (DES) Registry (ABLUMINUS BTK) - First in Men
Lead sponsor
Concept Medical Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
August 20, 2020
Completion date
December 2, 2024
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arterial disease of legs, atherosclerosis, peripheral artery disease